allogeneic human mesenchymal stem cells (allo-hMSCs): Clinical Trials

2 completed, 1 no longer available. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 2
Phase 2	2	Completed 2

Follow allogeneic human mesenchymal stem cells (allo-hMSCs): new trials by email Literature Review of allogeneic human mesenchymal stem cells (allo-hMSCs) trials Research Report on allogeneic human mesenchymal stem cells (allo-hMSCs)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression. allogeneic human mesenchymal stem cells (allo-hMSCs), Placebo - Major Depressive Disorder, Alcohol Use Disorder	Phase 1 / Phase 2	Completed	Ihsan M Salloum, MD, MPH	31	2018-03-18	2026-01-09
AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs), Placebo, Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs) - Frailty	Phase 1 / Phase 2	Completed	Longeveron Inc.	65	2014-03-03	2021-07-14
Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND) Allogeneic human mesenchymal stem cells (Allo-hMSCs) - Acute Ischemic Stroke, Mesenchymal Stem Cells		No longer available	University of Miami			2026-04-13

Conditions studied

Alcoholism (1)  ·  Depressive Disorder, Major (1)  ·  Frailty (1)  ·  Ischemic Stroke (1)  ·  Stroke (1)

Sponsors

Ihsan M Salloum, MD, MPH (1)  ·  Longeveron Inc. (1)  ·  University of Miami (1)

Countries

United States (3)

Top investigators

Dileep Yavagal, MD (1)  ·  Ihsan Salloum, MD (1)  ·  Joshua M Hare, MD (1)

NIH funding

R01AA024933 (1)